spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Outsourcing in Clinical Trials Europe 2020 Key Topics

Outsourcing in Clinical Trials Europe 2020


London – Hosted in Paris on 6-7 May, the 10th European edition of the Outsourcing in Clinical Trials Conference (https://www.arena-international.com/octeurope) will focus on developing best practices and incorporating novel technologies to meet the demands of complex global clinical trials.

The Clinical Trials market continues its growth because of increasing R&D expenditure in pharmaceutical and biopharmaceutical companies, globalisation of clinical trials and harmonisation of regulations. However, reductions are expected in the growth of this market because of increasing cost of drug development and clinical trials.

Outsourcing in Clinical Trials Europe is a leading conference for clinical trial community that brings together 500+ industry leaders to share their success stories and discuss solutions for accelerating clinical trial timelines while maintaining reasonable costs. Some of the key topics to be covered include:

1. Patient Engagement. Patient recruitment and retention are some of the most complex and constant challenges for a Trial Sponsor. How do you encourage people to take part in something so risky, time consuming, invasive, and inconvenient? How do you ensure commitment once they sign up? Lode Dewulf, Chief Patient Officer of Servier will give an update on key challenges associated with patient engagement complex protocols and benefits of sponsors collaboration.

2. Harnessing benefits of AI applications to pharma and healthcare. Andrew Graley, Industry Solutions Manager, EMEA and Elena Bonfiglioli, Health and Life Sciences EMEA at Microsoft Worldwide Health & Life Sciences will talk about the health data strategy and ethical aspects of digital clinical trials and AI.

3. Key considerations for a rapid study start up: the sponsor vs CRO. It is important to develop the internal strategy for CRO management during start-up to meet deliverables. The session will highlight the necessity of strong communication plan and innovative technologies to track moving pieces during start-up and real-time updates for both parties.

4. Moving towards site-less trials. ‘Virtual trials’ are something that are taking off in the US but not so much in Europe. This session will teach people what they can learn from the US experience. Rasmus Hogreffe, Head of Virtual Clinical Trials of LEO Innovation Lab will explain how to navigate the complexity of country-specific regulations and which EU countries do consider virtual trials. Maybe it’s best to have a hybrid model by mixing traditional and remote methods?

5. Pharma industry and wearable technology. This session will give 5 key takeaways for how and why wearables should be incorporated into the study. Adam Baumgart, Global Head, Quality, Training & Risk Management of AstraZeneca and Rasmus Hogreffe, Head of Virtual Clinical Trials of LEO Innovation Lab will talk about challenges when shifting to wearables and how to overcome them whilst ensuring patient safety.

6. Understanding clinical trial protocol. In this session brief case studies will be provided by Frank Berger, Head of Analytics, Global Clinical Operations of Boehringer Ingelheim and Denise Lee, Head Clinical Operations of Allergy Therapeutics explaining how to assess protocol complexity, how do we communicate about it and what do we do with the data. About the Outsourcing in Clinical Trials Conference The aim of the Outsourcing in Clinical Trials Conference is to optimize strategies to create an operationally efficient, specifically targeted clinical trial. The 10th European Outsourcing in Clinical Trials Conference is taking place in Espace Grande Arche, Paris on 6-7 May 2020. Other editions of this international series will be hosted in East Coast (19-20 May, King of Prussia), UK & Ireland (27-28 May, London), New England (30 Sept – 1 Oct, Boston), DACH (7-8 October, Zurich), Pacific North West (20-21 October, Seattle), Nordics (20-21 October, Copenhagen), Southern California (27-28 October, San Diego), Mid-Atlantic (10-11 November, Maryland) and East Asia (8-9 December).

More information is available on: https://www.arena-international.com/healthcare

About Arena International
Arena International Events Group (part of GlobalData) welcomes over 10,000 business executives each year who attend over 80 of our events worldwide, they are addressed by over 1,700 industry leaders delivering leading edge content and discussion.

Arena International’s events consistently strive to provide thought-provoking content and unrivalled networking opportunities, which add tangible value to those who attend. With comprehensive learning programmes, wide-ranging exhibitions and extensive networking activities we bring together industries to collaborate and learn. www.arena-international.com

Further Information
For Further information, please contact:

Katie Giorgadze
PR & Marketing Manager
Tel: +44 (0) 20 7936 6656
web https://www.arena-international.com/octeurope/
email Espace Grande Arche
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>


White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement